{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:45Z","timestamp":1753890945596,"version":"3.41.2"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Epidemiological surveillance has raised safety concerns for mRNA SARS-CoV-2-vaccination-related myocarditis. We aimed to analyze epidemiological, clinical and imaging findings associated with clinical outcomes in these patients in an international multi-center registry (NCT05268458).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>Patients with clinical and CMR diagnosis of acute myocarditis within 30 days after mRNA SARS-CoV-2\u2014vaccination were included from five centers in Canada and Germany between 05\/21 and 01\/22. Clinical follow-up on persistent symptoms was collected. We enrolled 59 patients (80% males, mean age 29 years) with CMR-derived mild myocarditis (hs-Troponin-T 552 [249\u20131,193] ng\/L, CRP 28 [13\u201351] mg\/L; LVEF 57\u2009\u00b1\u20097%, LGE 3 [2\u20135] segments). Most common symptoms at baseline were chest pain (92%) and dyspnea (37%). Follow-up data from 50 patients showed overall symptomatic burden improvement. However, 12\/50 patients (24%, 75% females, mean age 37 years) reported persisting symptoms (median interval 228 days) of chest pain (<jats:italic>n<\/jats:italic>\u2009=\u20098\/12, 67%), dyspnea (<jats:italic>n<\/jats:italic>\u2009=\u20097\/12, 58%), with increasing occurrence of fatigue (<jats:italic>n<\/jats:italic>\u2009=\u20095\/12, 42%) and palpitations (<jats:italic>n<\/jats:italic>\u2009=\u20092\/12, 17%). These patients had initial lower CRP, lower cardiac involvement in CMR, and fewer ECG changes. Significant predictors of persisting symptoms were female sex and dyspnea at initial presentation. Initial severity of myocarditis was not associated with persisting complaints.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A relevant proportion of patients with mRNA SARS-CoV-2-vaccination-related myocarditis report persisting complaints. While young males are usually affected, patients with persisting symptoms were predominantly females and older. The severity of the initial cardiac involvement not predicting these symptoms may suggest an extracardiac origin.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1204232","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T09:52:25Z","timestamp":1687341145000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of persistent symptoms after mRNA SARS-CoV-2 vaccine-related myocarditis (myovacc registry)"],"prefix":"10.3389","volume":"10","author":[{"given":"Daniel","family":"Schroth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ria","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xhoi","family":"Bocova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Haass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binita","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Mustafa","family":"Alhussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin","family":"Giusca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigorios","family":"Korosoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias G.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23970\/AHRQEPCERTA215","article-title":"Safety of vaccines used for routine immunization in the United States","author":"Maglione","year":"2014","journal-title":"Evid Rep Technol Assess"},{"year":"","key":"B2"},{"year":"","key":"B3"},{"year":"","key":"B4"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMOA2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMOA2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"N Engl J Med"},{"year":"","key":"B7"},{"year":"","key":"B8"},{"year":"","key":"B9"},{"key":"B10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/J.IJCARD.2018.09.054","article-title":"Myocarditis and pericarditis after immunization: gaining insights through the vaccine adverse event reporting system","volume":"273","author":"Mei","year":"2018","journal-title":"Int J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/J.VACCINE.2015.07.035","article-title":"Safety monitoring in the vaccine adverse event reporting system (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMOA2110475","article-title":"Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting","volume":"101","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.15585\/MMWR.MM7027E2","article-title":"Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices\u2014United States, June 2021","volume":"70","author":"Gargano","year":"2021","journal-title":"Morb Mortal Wkly Rep"},{"year":"","key":"B14"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/EJHF.2669","article-title":"Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective","author":"Heidecker","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/J.JACC.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1161\/CIR.0000000000001030","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial sementation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.22091.11046","article-title":"Cut-off values for myocardial mapping Z-scores for identifying cardiomyopathies","author":"Garg","year":"2021"},{"year":"","key":"B20"},{"year":"","key":"B21"},{"year":"","key":"B22"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ-2021-068665","article-title":"SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study","volume":"375","author":"Husby","year":"2021","journal-title":"Br Med J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1056\/NEJMOA2110737","article-title":"Myocarditis after COVID-19 vaccination in a large health care organization","volume":"385","author":"Witberg","year":"2021","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/JPM11111106","article-title":"Myocarditis and pericarditis following COVID-19 vaccination: inequalities in age and vaccine types","volume":"11","author":"Li","year":"2021","journal-title":"J Pers Med"},{"year":"","key":"B26"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMOA2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1007\/S00330-022-08566-0","article-title":"Cardiac magnetic resonance imaging of myocarditis and pericarditis following COVID-19 vaccination: a multicenter collection of 27 cases","volume":"32","author":"Di Dedda","year":"2022","journal-title":"Eur Radiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1016\/j.vaccine.2021.05.087","article-title":"Myocarditis following COVID-19 mRNA vaccination","volume":"39","author":"Mouch","year":"2021","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1001\/jamacardio.2021.2828","article-title":"Patients with acute myocarditis following mRNA COVID-19 vaccination","author":"Kim","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/jamacardio.2021.2833","article-title":"Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military","author":"Montgomery","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-021-00795-4","article-title":"Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series","volume":"23","author":"Patel","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/J.JCMG.2021.06.002","article-title":"Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings","volume":"14","author":"Shaw","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.121.055891","article-title":"Myocarditis temporally associated with COVID-19 vaccination","volume":"144","author":"Rosner","year":"2021","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/JAMA.2021.13443","article-title":"Myocarditis and pericarditis after vaccination for COVID-19","volume":"326","author":"Diaz","year":"2021","journal-title":"J Am Med Assoc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3389\/FCVM.2022.990108\/BIBTEX","article-title":"Case report: case series of isolated acute pericarditis after SARS-CoV-2 vaccinations","volume":"9","author":"Ochs","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12968-020-00683-3","article-title":"Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update","volume":"22","author":"Kawel-Boehm","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/JAMACARDIO.2019.2724","article-title":"Myocardial injury in the era of high-sensitivity cardiac troponin assays: a practical approach for clinicians","volume":"4","author":"McCarthy","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1089\/JWH.2021.0411","article-title":"Sex-related differences in long-COVID-19 syndrome","volume":"31","author":"Pel\u00e0","year":"2022","journal-title":"J Womens Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"611.e9","DOI":"10.1016\/J.CMI.2021.11.002\/ATTACHMENT\/1AFE6439-ACC5-4CF2-8745-5B5E0FA2EB24\/MMC3.DOCX","article-title":"Female gender is associated with long COVID syndrome: a prospective cohort study","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"B41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/J.MAYOCP.2021.11.033","article-title":"The female-predominant persistent immune dysregulation of the post-COVID syndrome","volume":"97","author":"Ganesh","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"B42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/IMM.13487","article-title":"The immune response to COVID-19: does sex matter?","volume":"166","author":"Ho","year":"2022","journal-title":"Immunology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/J.CELL.2018.10.022","article-title":"Impact of genetic polymorphisms on human immune cell gene expression","volume":"175","author":"Schmiedel","year":"2018","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/S40246-018-0185-Z","article-title":"The X chromosome and sex-specific effects in infectious disease susceptibility","volume":"13","author":"Schurz","year":"2019","journal-title":"Hum Genomics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/BIES.201100047","article-title":"X-chromosome-located microRNAs in immunity: might they explain male\/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females","volume":"33","author":"Pinheiro","year":"2011","journal-title":"Bioessays"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1001\/ARCHINTERNMED.2008.513","article-title":"Half- vs full-dose trivalent inactivated influenza vaccine (2004\u20132005): age, dose, and sex effects on immune responses","volume":"168","author":"Engler","year":"2008","journal-title":"Arch Intern Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/J.CLIM.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.120.050354","article-title":"Severe COVID-19 is a microvascular disease","volume":"142","author":"Lowenstein","year":"2020","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3389\/FCVM.2021.745758\/BIBTEX","article-title":"Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study","volume":"8","author":"Charfeddine","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/FCVM.2021.636843\/XML\/NLM","article-title":"Microvascular angiopathic consequences of COVID-19","volume":"8","author":"Nalugo","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3389\/FCVM.2022.877416","article-title":"Brief research report: quantitative analysis of potential coronary microvascular disease in suspected long-COVID syndrome","author":"Doeblin","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/J.REC.2021.10.010","article-title":"Long COVID-19 and microvascular disease-related angina","volume":"75","author":"Camaz\u00f3n","year":"2022","journal-title":"Rev Esp Cardiol"},{"year":"2022","author":"Garg","key":"B53"},{"key":"B54","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/J.JACBTS.2021.10.011","article-title":"The pathogenesis and long-term consequences of COVID-19 cardiac injury","volume":"7","author":"Siripanthong","year":"2022","journal-title":"JACC Basic Transl Sci"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1204232\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T09:52:29Z","timestamp":1687341149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1204232\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":54,"alternative-id":["10.3389\/fcvm.2023.1204232"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1204232","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"article-number":"1204232"}}